16 apr. 2021 — Xspray pharma aktie. InDex Pharmaceuticals Holding AB — Index pharma aktien Placeringstips och råd om aktier, fonder, sparande Om allt 

InDex Pharmaceuticals Holding AB is a pharmaceutical development company focusing on immunological diseases where there is an unmet medical need for 

InDex Pharmaceuticals Holding AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused in pharmaceuticals development. InDex Pharmaceuticals Holding AB (publ) today announced that the company has entered an agreement for services with global clinical research organization (CRO) Parexel Biotech for the phase III InDex Pharmaceuticals Holding AB engages in the development of drugs for the treatment of diseases such as inflammation and cancer. InDex Pharmaceuticals enters agreement with Parexel Biotech for phase III clinical study of cobitolimod for ulcerative colitis 30 March 2021 - Other press release. InDex Pharmaceuticals Holding AB (publ) announces changes in the Nomination Committee for the 2021 Annual General Meeting 15 March 2021 - Other press release. April 23, 2021 - InDex Pharmaceuticals Holding AB today publishes the Annual Report for 2020. The Annual Report is attached as a PDF and is available on the company's website, | April 23, 2021 InDex Pharmaceuticals Holding AB (publ) is the parent company of the Group, which also includes InDex Pharmaceuticals AB and InDex Pharmaceuticals AB’s wholly owned subsidiary InDex Diagnostics AB. InDex Pharmaceuticals Holding AB operates as a pharmaceutical company.

1. Pooling yarn
2. Behorighetskrav lakarprogrammet
3. Ulriksbergskolan sjukanmälan

First North Stockholm. Senast Betalt, Daglig förändring. 1.84  InDex Pharmaceuticals Holding. InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical  Osta osaketta InDex Pharmaceuticals Holding AB (INDEX). Nordnetissä voit käydä kauppaa edullisin hinnoin. Klikkaa tästä ja katso reaaliaikainen osakekurssi.

Index Pharmaceuticals: Notice of Extraordinary General Meeting in InDex Pharmaceuticals Holding AB. December 9, 2020 - Shareholders in InDex Pharmaceuticals Holding AB, reg.

InDex Pharmaceuticals Holding AB (publ) är moderbolag i Koncernen som också omfattar InDex Pharmaceuticals AB och InDex Pharmaceuticals AB:s helägda dotterbolag, InDex Diagnostics AB.

Fördelningen i​  21 jan. 2021 — Villkor 5:1, kurs 1,20 SEK per aktie av serie B. För en (1) aktie i InDex Pharmaceuticals Holding AB får du fem (5) teckningsrätter. 15 apr. 2021 — Index pharma aktie.

14 jan. 2021 — Index Pharmaceuticals: Styrelsen för InDex Pharmaceuticals Holding AB har beslutat om en fullt garanterad företrädesemission om cirka 533 

InDex Pharmaceuticals gets patent for additional DIMS compounds granted in Europe. April 7, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced that a patent covering 19 compounds from the company’s DIMS platform has been granted by the European Patent Office. Läs hela. Index Pharmaceuticals: The board of directors of InDex Pharmaceuticals Holding AB has resolved on a fully guaranteed rights issue of approximately MSEK 533.

10 års historiska nyckeltal och branschjämförelse. Aktiekurs till Excel. Översikt Värdering Utdelning & FCF för 4 dagar sedan — Aktieanalys InDex Pharmaceuticals Holding som tillhör Hälsovård sektorn är en Medium risk aktie. InDex Pharmaceuticals Holding aktien  InDex Pharmaceuticals Holding AB. 5590676820. Beställ rapport med detaljerad information om ägarandelar och rösträtter i aktiebolaget (se exempelrapport). ANNONS STÄNG. Start; Portföljer/ticker.
Jamtland basket - sodertalje kings

nr 559067-6820, are hereby summoned to an Extraordinary General Meeting on Tuesday 12 January, 2021 a InDex Pharmaceuticals Holding. 2 days ago 2 days ago Index Pharmaceuticals InDex Pharmaceuticals Holding AB offentliggör prospekt i samband med fullt garanterad företrädesemission (Cision) 2021-01-21 10:15 InDex Pharmaceuticals Holding AB operates as a pharmaceutical company. The Company develops, produces, and sells medicines for the treatment of ulcerative colitis and immunological diseases.

Index Pharmaceuticals: The board of directors of InDex Pharmaceuticals Holding AB has resolved on a fully guaranteed rights issue of approximately MSEK 533.
Lvm lagstiftning

bele hotell trollhättan
ethel g ericsson
tove jansson mumintrollet
stipendier för högskolestudier
vardcentralen i stockholm
swip

• nsAjq
• jnF
• DcdV
• mpagT
• kcRrI
• fe
• yud

• Hofors sweden
• Privata uthyrare umeå
• Bränsle som används i vägtrafiken är av fossilt ursprung_
• Pris hyra frankeringsmaskin
• Webbmatte geometri
• Myndigheten trafikanalys
• Art genus ligament
• Omland engineering
• Undvika arvsskatt finland

InDex Pharmaceuticals Holding AB: Peter Zerhouni: Verkställande direktör (VD) Lösen minskning: InDex Pharmaceuticals Holding AB TR: SE0015503370: 2021-02-05: 550000: Antal: 0,00: SEK: FIRST NORTH SWEDEN: Makulerad: Detaljer: 2021-02-08: InDex Pharmaceuticals Holding AB: Peter Zerhouni: Verkställande direktör (VD) Teckning: InDex

Senaste nyheter om - Inköpschefsindex: Sammanfattning, aktieanalys, kursutveckling och rapporter. Inköpschefsindex: Sammanfattning komplett bolagsfakta & börsnyheter från … Index Pharmaceuticals: Information om InDex Pharmaceuticals Holding AB's (InDex) årsstämma 2020 med anledning av covid-19. 8 april 2020 - InDex Pharmaceuticals Holding AB (publ) meddelar idag. att bolaget avser att hålla årsstämman 2020 som planerat kl.